Literature DB >> 16387648

Reevaluation of the PPAR-beta/delta ligand binding domain model reveals why it exhibits the activated form.

Stewart A Fyffe1, Magnus S Alphey, Lori Buetow, Terry K Smith, Michael A J Ferguson, Morten D Sørensen, Fredrik Björkling, William N Hunter.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16387648     DOI： 10.1016/j.molcel.2005.12.001

Source DB:  PubMed          Journal:  Mol Cell        ISSN： 1097-2765            Impact factor:   17.970


× No keyword cloud information.
  15 in total

1.  Chronic AMP-activated protein kinase activation and a high-fat diet have an additive effect on mitochondria in rat skeletal muscle.

Authors:  Natasha Fillmore; Daniel L Jacobs; David B Mills; William W Winder; Chad R Hancock
Journal:  J Appl Physiol (1985)       Date:  2010-06-03

2.  An assessment of three human methylenetetrahydrofolate dehydrogenase/cyclohydrolase-ligand complexes following further refinement.

Authors:  Renata Bueno; Alice Dawson; William N Hunter
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2019-02-20       Impact factor: 1.056

3.  Quantitative expression patterns of peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) protein in mice.

Authors:  Elizabeth E Girroir; Holly E Hollingshead; Pengfei He; Bokai Zhu; Gary H Perdew; Jeffrey M Peters
Journal:  Biochem Biophys Res Commun       Date:  2008-04-28       Impact factor: 3.575

Review 4.  Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.

Authors:  Jeffrey M Peters; Holly E Hollingshead; Frank J Gonzalez
Journal:  Clin Sci (Lond)       Date:  2008-08       Impact factor: 6.124

Review 5.  Establishing the Role of PPARβ/δ in Carcinogenesis.

Authors:  Jeffrey M Peters; Frank J Gonzalez; Rolf Müller
Journal:  Trends Endocrinol Metab       Date:  2015-10-18       Impact factor: 12.015

6.  Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and pan-PPAR partial agonists.

Authors:  Marcelo Vizoná Liberato; Alessandro S Nascimento; Steven D Ayers; Jean Z Lin; Aleksandra Cvoro; Rodrigo L Silveira; Leandro Martínez; Paulo C T Souza; Daniel Saidemberg; Tuo Deng; Angela Angelica Amato; Marie Togashi; Willa A Hsueh; Kevin Phillips; Mário Sérgio Palma; Francisco A R Neves; Munir S Skaf; Paul Webb; Igor Polikarpov
Journal:  PLoS One       Date:  2012-05-23       Impact factor: 3.240

7.  Structures of three MORN repeat proteins and a re-evaluation of the proposed lipid-binding properties of MORN repeats.

Authors:  Sara Sajko; Irina Grishkovskaya; Julius Kostan; Melissa Graewert; Kim Setiawan; Linda Trübestein; Korbinian Niedermüller; Charlotte Gehin; Antonio Sponga; Martin Puchinger; Anne-Claude Gavin; Thomas A Leonard; Dimitri I Svergun; Terry K Smith; Brooke Morriswood; Kristina Djinovic-Carugo
Journal:  PLoS One       Date:  2020-12-09       Impact factor: 3.752

Review 8.  Integrative and systemic approaches for evaluating PPARβ/δ (PPARD) function.

Authors:  Greta M P Giordano Attianese; Béatrice Desvergne
Journal:  Nucl Recept Signal       Date:  2015-04-27

9.  Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4.

Authors:  Combiz Khozoie; Michael G Borland; Bokai Zhu; Songjoon Baek; Sam John; Gordon L Hager; Yatrik M Shah; Frank J Gonzalez; Jeffrey M Peters
Journal:  BMC Genomics       Date:  2012-11-24       Impact factor: 3.969

10.  Structure-based virtual screening and discovery of New PPARδ/γ dual agonist and PPARδ and γ agonists.

Authors:  Vinicius G Maltarollo; Marie Togashi; Alessandro S Nascimento; Kathia M Honorio
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.